ADA Scientific Sessions 2026 Abstract

IBI3032: An Orally Bioavailable Nonpeptidic GLP-1 Receptor Agonist Advancing through Phase 1 Clinical Trials

By Ye Jiang, Jiali Ding, Yao Xiong, Nan Yu, Decheng Ren

Experiments in animalsInterventions

The paper

Ye Jiang, Jiali Ding, Yao Xiong, Nan Yu, Decheng Ren

Suzhou

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1678-P

doi.org/10.2337/db26-1678-p

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity